• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国国家卫生研究院卫生技术评估(HTA)计划资助研究的回报:经济分析与案例研究

Returns on Research Funded Under the NIHR Health Technology Assessment (HTA) Programme: Economic Analysis and Case Studies.

作者信息

Guthrie Susan, Hafner Marco, Bienkowska-Gibbs Teresa, Wooding Steven

出版信息

Rand Health Q. 2016 May 9;5(4):5.

PMID:28083415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5158220/
Abstract

The Department of Health (England) requested that RAND Europe conduct an economic analysis of the impact of the HTA Programme. This article describes the results of that work, which consisted of analysis of the potential economic benefits of a sample of HTA funded studies and comparison to programme costs, supplemented by a set of short case studies exploring the impacts of the HTA Programme on policy and practice. Based on our analysis, if 12 per cent of the potential net benefit of implementing the findings of this sample of 10 studies for one year was realised, it would cover the cost of the HTA Programme from 1993 to 2012. Drawing on the case studies and the economic analysis, we have also made a number of observations that could help ensure that the HTA Programme maximises the likelihood of findings being adopted.

摘要

英国卫生部要求兰德欧洲公司对卫生技术评估(HTA)项目的影响进行经济分析。本文介绍了该工作的结果,包括对HTA资助研究样本的潜在经济效益分析以及与项目成本的比较,并辅以一系列探索HTA项目对政策和实践影响的简短案例研究。根据我们的分析,如果将这10项研究样本的结果实施一年后潜在净收益的12%实现,就将覆盖1993年至2012年HTA项目的成本。借鉴案例研究和经济分析,我们还提出了一些有助于确保HTA项目最大程度提高研究结果被采用可能性的观点。

相似文献

1
Returns on Research Funded Under the NIHR Health Technology Assessment (HTA) Programme: Economic Analysis and Case Studies.英国国家卫生研究院卫生技术评估(HTA)计划资助研究的回报:经济分析与案例研究
Rand Health Q. 2016 May 9;5(4):5.
2
Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort.英国国家卫生研究院卫生技术评估项目资助的研究对英国国家卫生与临床优化研究所临床指南的影响:一项回顾性队列研究。
Health Res Policy Syst. 2015 Aug 22;13:37. doi: 10.1186/s12961-015-0025-8.
3
Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.评估卫生技术评估的国际应用:探讨不同方法在应用于英国国家卫生与临床优化研究所卫生技术评估(NIHR HTA)计划时的优缺点。
Int J Technol Assess Health Care. 2013 Apr;29(2):192-7. doi: 10.1017/S026646231300010X. Epub 2013 Apr 3.
4
Time to publication for NIHR HTA programme-funded research: a cohort study.英国国家卫生与临床优化研究所(NIHR)卫生技术评估(HTA)项目资助的研究的出版时间:一项队列研究。
BMJ Open. 2013 Nov 27;3(11):e004121. doi: 10.1136/bmjopen-2013-004121.
5
6
The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study.英国国家卫生研究院卫生技术评估(NIHR HTA)资助研究的临床相关性和新闻价值:一项队列研究。
BMJ Open. 2014 May 7;4(5):e004556. doi: 10.1136/bmjopen-2013-004556.
7
Prioritizing investments in health technology assessment. Can we assess potential value for money?优先考虑卫生技术评估方面的投资。我们能否评估潜在的性价比?
Int J Technol Assess Health Care. 2000 Winter;16(1):73-91. doi: 10.1017/s0266462300016172.
8
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.英国国家卫生研究院(NIHR)卫生技术评估(HTA)项目研究资金与英国疾病负担
Trials. 2018 Feb 2;19(1):87. doi: 10.1186/s13063-018-2489-7.
9
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.一项关于将决策理论和信息价值分析作为英国国家医疗服务体系(NHS)卫生技术评估计划一部分加以运用的试点研究。
Health Technol Assess. 2004 Jul;8(31):1-103, iii. doi: 10.3310/hta8310.
10
Health technology assessment: research trends and future priorities in Europe.卫生技术评估:欧洲的研究趋势和未来重点。
J Health Serv Res Policy. 2011 Jul;16 Suppl 2:6-15. doi: 10.1258/jhsrp.2011.011050.

引用本文的文献

1
Activities critical to success and growth of clinical trials networks. What is needed and how are we doing? An Australian and New Zealand perspective.临床试验网络成功和发展的关键活动。我们需要什么,我们做得如何?澳大利亚和新西兰的观点。
Trials. 2023 Nov 4;24(1):707. doi: 10.1186/s13063-023-07709-y.
2
How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review.最不发达国家和中下等收入国家如何使用卫生技术评估:范围综述。
Pathog Glob Health. 2023 Mar;117(2):104-119. doi: 10.1080/20477724.2022.2106108. Epub 2022 Aug 10.
3
What funders are doing to assess the impact of their investments in health and biomedical research.资助者正在评估他们在健康和生物医学研究方面投资的影响。
Health Res Policy Syst. 2022 Aug 9;20(1):88. doi: 10.1186/s12961-022-00888-1.
4
What is the value of explicit priority setting for health interventions? A simulation study.明确优先事项设定在卫生干预措施中的价值是什么?一项模拟研究。
Health Care Manag Sci. 2022 Sep;25(3):460-483. doi: 10.1007/s10729-022-09594-4. Epub 2022 May 28.
5
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making.规避卫生技术评估:关于决策过程中不采用卫生技术评估原因的全球调查
Cost Eff Resour Alloc. 2021 Sep 22;19(1):62. doi: 10.1186/s12962-021-00308-1.
6
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.评估卫生技术评估(HTA)机构的绩效:构建一个多国、多利益相关方和多维度的框架以探索影响机制。
Cost Eff Resour Alloc. 2021 Jul 2;19(1):37. doi: 10.1186/s12962-021-00290-8.
7
Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.氨甲环酸减少创伤性脑损伤患者的颅脑损伤死亡:CRASH-3 国际 RCT。
Health Technol Assess. 2021 Apr;25(26):1-76. doi: 10.3310/hta25260.
8
[Not Available].[不可用]。
CMAJ. 2021 Apr 6;193(14):E497-E501. doi: 10.1503/cmaj.202397-f.
9
The value proposition of investigator-initiated clinical trials conducted by networks.由网络开展的研究者发起的临床试验的价值主张。
Med J Aust. 2021 Mar;214(4):159-161.e1. doi: 10.5694/mja2.50935. Epub 2021 Feb 14.
10
Integrating research into clinical practice: challenges and solutions for Canada.将研究融入临床实践:加拿大面临的挑战与解决方案
CMAJ. 2021 Jan 25;193(4):E127-E131. doi: 10.1503/cmaj.202397. Epub 2020 Dec 9.

本文引用的文献

1
What decision-makers want and what they have been getting.决策者想要的东西以及他们一直得到的东西。
Value Health. 2006 May-Jun;9(3):181-5. doi: 10.1111/j.1524-4733.2006.00098.x.
2
Assessing the impact of health technology assessment.评估卫生技术评估的影响。
Int J Technol Assess Health Care. 1997 Winter;13(1):68-80. doi: 10.1017/s0266462300010242.
3
Assessing technology assessment. Early results of the Quebec experience.评估技术评估:魁北克经验的早期结果
Int J Technol Assess Health Care. 1993 Fall;9(4):564-72. doi: 10.1017/s0266462300005481.